Anja Wessely

905 total citations
40 papers, 511 citations indexed

About

Anja Wessely is a scholar working on Oncology, Epidemiology and Dermatology. According to data from OpenAlex, Anja Wessely has authored 40 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Epidemiology and 15 papers in Dermatology. Recurrent topics in Anja Wessely's work include Nonmelanoma Skin Cancer Studies (20 papers), Cutaneous Melanoma Detection and Management (20 papers) and Cutaneous lymphoproliferative disorders research (11 papers). Anja Wessely is often cited by papers focused on Nonmelanoma Skin Cancer Studies (20 papers), Cutaneous Melanoma Detection and Management (20 papers) and Cutaneous lymphoproliferative disorders research (11 papers). Anja Wessely collaborates with scholars based in Germany, Netherlands and United States. Anja Wessely's co-authors include Markus V. Heppt, Carola Berking, Theresa Steeb, Michael Erdmann, Anne Petzold, Lars E. French, Julio Vera, Titus J. Brinker, Thomas Ruzicka and Ulrike Leiter and has published in prestigious journals such as Scientific Reports, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Anja Wessely

37 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anja Wessely Germany 16 275 164 136 118 101 40 511
J.A. Avilés-Izquierdo Spain 11 293 1.1× 140 0.9× 124 0.9× 58 0.5× 40 0.4× 49 445
Per Helsing Norway 14 264 1.0× 292 1.8× 361 2.7× 88 0.7× 53 0.5× 40 645
J.F. Baurain Belgium 9 191 0.7× 50 0.3× 29 0.2× 102 0.9× 52 0.5× 26 327
K.W. Schulte Germany 13 550 2.0× 310 1.9× 197 1.4× 225 1.9× 124 1.2× 37 817
Robert V. Rawson Australia 14 461 1.7× 71 0.4× 49 0.4× 200 1.7× 155 1.5× 49 599
Adi Nosrati United States 13 671 2.4× 124 0.8× 107 0.8× 210 1.8× 354 3.5× 22 911
Christopher W. Schacherer United States 9 706 2.6× 235 1.4× 86 0.6× 235 2.0× 124 1.2× 18 845
Olga Vornicova Israel 9 233 0.8× 181 1.1× 108 0.8× 78 0.7× 54 0.5× 23 377
J. Bertz Germany 11 525 1.9× 169 1.0× 181 1.3× 167 1.4× 78 0.8× 19 654
Aram Boada Spain 13 237 0.9× 131 0.8× 171 1.3× 122 1.0× 116 1.1× 68 515

Countries citing papers authored by Anja Wessely

Since Specialization
Citations

This map shows the geographic impact of Anja Wessely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Wessely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Wessely more than expected).

Fields of papers citing papers by Anja Wessely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Wessely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Wessely. The network helps show where Anja Wessely may publish in the future.

Co-authorship network of co-authors of Anja Wessely

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Wessely. A scholar is included among the top collaborators of Anja Wessely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Wessely. Anja Wessely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liguori, Renato, Alessandra Marnie Martins Gomes de Castro, Stefan Schliep, et al.. (2025). Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8. International Journal of Molecular Sciences. 26(20). 9964–9964.
2.
Petzold, Anne, Anja Wessely, Michael Erdmann, et al.. (2025). An artificial intelligence model of whole-slide pathology specimens differentiating cutaneous high-grade squamous proliferations. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(5). 1047–1058.
3.
Lai, Xin, Chunyan Luan, Anja Wessely, et al.. (2025). SOX10 , MITF , and microRNAs : Decoding their interplay in regulating melanoma plasticity. International Journal of Cancer. 157(7). 1277–1293. 1 indexed citations
4.
Petzold, Anne, et al.. (2025). Actinic Cheilitis: A Systematic Review and Meta-Analysis of Interventions, Treatment Outcomes, and Adverse Events. Biomedicines. 13(8). 1896–1896. 1 indexed citations
5.
Petzold, Anne, Anja Wessely, Theresa Steeb, Carola Berking, & Markus V. Heppt. (2024). Efficacy of interventions for cutaneous squamous cell carcinoma in situ (Bowen's disease): A systematic review and meta‐analysis of proportions. Journal of the European Academy of Dermatology and Venereology. 39(3). 543–554. 1 indexed citations
6.
Steeb, Theresa, Anja Wessely, Markus V. Heppt, et al.. (2023). Opportunities to inform German residents about the possibility of skin cancer screening and to inform stakeholders to take appropriate actions: A qualitative approach. Cancer Medicine. 12(9). 10829–10839. 1 indexed citations
7.
Petzold, Anne, Theresa Steeb, Anja Wessely, et al.. (2023). Is tebentafusp superior to combined immune checkpoint blockade and other systemic treatments in metastatic uveal melanoma? A comparative efficacy analysis with population adjustment. Cancer Treatment Reviews. 115. 102543–102543. 18 indexed citations
8.
Petzold, Anne, Anja Wessely, Harald Knorr, et al.. (2023). Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma – A Single Center Analysis. Anticancer Research. 43(10). 4525–4532.
9.
Heppt, Markus V., Anja Wessely, Claudia Kammerbauer, et al.. (2022). HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma. International Journal of Molecular Sciences. 23(2). 849–849. 7 indexed citations
10.
Petzold, Anne, Theresa Steeb, Anja Wessely, et al.. (2022). Comparative efficacy analysis identifies immune checkpoint blockade as a new survival benchmark in advanced cutaneous squamous cell carcinoma. European Journal of Cancer. 170. 42–53. 6 indexed citations
11.
Steeb, Theresa, Anja Wessely, Caroline Voskens, et al.. (2021). Experiences of In-Patients with Skin Cancer in a German University Hospital Setting: A Cross-Sectional Survey. Patient Preference and Adherence. Volume 15. 41–48. 1 indexed citations
12.
Steeb, Theresa, Anja Wessely, Michael Constantin Kirchberger, et al.. (2021). “I Feel I’m in Best Hands with You!”: A Survey of Patient Satisfaction in a German University Skin Cancer Centre. Acta Dermato Venereologica. 101(6). adv00482–adv00482. 1 indexed citations
13.
Steeb, Theresa, Markus V. Heppt, Michael Erdmann, et al.. (2021). Increasing Participation Rates in Germany’s Skin Cancer Screening Program (HELIOS): Protocol for a Mixed Methods Study. JMIR Research Protocols. 10(12). e31860–e31860. 2 indexed citations
14.
Steeb, Theresa, Anja Wessely, Anne Petzold, et al.. (2021). Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis. JAMA Dermatology. 157(9). 1066–1066. 21 indexed citations
15.
Steeb, Theresa, Anja Wessely, Anne Petzold, et al.. (2021). c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis. European Journal of Cancer. 157. 348–357. 31 indexed citations
16.
Steeb, Theresa, Anja Wessely, Anne Petzold, et al.. (2021). Long-term recurrence rates of actinic keratosis: A systematic review and pooled analysis of randomized controlled trials. Journal of the American Academy of Dermatology. 86(5). 1116–1119. 18 indexed citations
17.
Steeb, Theresa, Anja Wessely, Titus J. Brinker, et al.. (2020). Patient Perception of Mobile Phone Apps for the Care and Prevention of Sexually Transmitted Diseases: Cross-Sectional Study. JMIR mhealth and uhealth. 8(11). e16517–e16517. 6 indexed citations
18.
Steeb, Theresa, Anja Wessely, Lutz Schmitz, et al.. (2020). Interventions for Actinic Keratosis in Nonscalp and Nonface Localizations: Results from a Systematic Review with Network Meta-Analysis. Journal of Investigative Dermatology. 141(2). 345–354.e8. 8 indexed citations
19.
Wessely, Anja, Theresa Steeb, Michael Erdmann, et al.. (2020). The Role of Immune Checkpoint Blockade in Uveal Melanoma. International Journal of Molecular Sciences. 21(3). 879–879. 55 indexed citations
20.
Steeb, Theresa, Anja Wessely, Lars E. French, Markus V. Heppt, & Carola Berking. (2019). Skin Cancer Smartphone Applications for German-speaking Patients: Review and Content Analysis Using the Mobile App Rating Scale. Acta Dermato Venereologica. 99(11). 1043–1044. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.A. Avilés-Izquierdo Breakdown of academic impact, for papers by Per Helsing Breakdown of academic impact, for papers by J.F. Baurain Breakdown of academic impact, for papers by K.W. Schulte Breakdown of academic impact, for papers by Robert V. Rawson Breakdown of academic impact, for papers by Adi Nosrati Breakdown of academic impact, for papers by Christopher W. Schacherer Breakdown of academic impact, for papers by Olga Vornicova Breakdown of academic impact, for papers by J. Bertz Breakdown of academic impact, for papers by Aram Boada
Rankless by CCL
2026